medRxiv (pronounced "med-archive") is the definitive preprint server for medicine and the health sciences. It was founded in June 2019 by Cold Spring Harbor Laboratory, Yale University, and BMJ, and grew rapidly during the COVID-19 pandemic, when it became a primary channel for sharing urgent clinical research. Since March 2025, medRxiv has been operated by openRxiv, an independent, researcher-led non-profit that also runs bioRxiv; the two servers together host more than 430,000 preprints, with roughly 5,000 new articles posted each month across the pair.

A medRxiv preprint is a complete, citable research manuscript posted online before (or in parallel with) journal peer review. Articles are not peer-reviewed, edited, or typeset before being posted - readers should treat findings as preliminary. Posting is free, articles receive DOIs, and authors retain copyright.

1. Register and submit. Create a free account at medrxiv.org and upload your manuscript files. There is no charge for registration or manuscript deposition.
2. Complete the medical-research declarations. medRxiv requires more than a standard preprint server: authors must declare that all necessary IRB/ethics approvals and patient consents were obtained, provide a competing-interest statement, and provide a funding statement. Any clinical trial described must be registered with an internationally recognized trial registry, and the registration number must be included.
3. Screening. Submissions go through a basic screening process - checks for plagiarism, offensive or non-scientific content, and material that might pose a health risk - performed by the medRxiv team with input from practicing health professionals. This usually completes within a few days. It is a moderation step, not peer review.
4. Posting and DOI. Approved manuscripts go online with a DOI and a prominent "not certified by peer review" notice.
5. Revisions. Authors are free to submit a revised version at any time prior to publication in a journal. Revised versions retain the same DOI, and all prior versions remain accessible.

medRxiv covers 60+ specialty categories across medicine and the health sciences - from addiction medicine, cardiology, and epidemiology to public health, psychiatry, and urology. It accepts complete research manuscripts, including clinical trials, observational studies, systematic reviews and meta-analyses, and methods papers.

It does not accept case reports, narrative reviews, theses, term papers, opinion pieces, or other non-research material. Work that could pose a biosecurity or public-health risk is also excluded at screening.

Because of this, media outlets and clinicians are cautioned against treating medRxiv preprints as established findings, and every article page carries that disclaimer.

Cite a medRxiv preprint the way you would cite any preprint: author(s), year, title, "medRxiv" as the source, and the DOI. Example (author-year style): Smith J, et al. (2026). Title of the preprint. medRxiv. https://doi.org/10.1101/2026.01.01.26300000. Most journals and citation styles (APA, Vancouver, AMA) now have explicit preprint formats - SciSpace's citation generator handles medRxiv automatically. If a preprint has since been published, prefer citing the journal version; medRxiv links preprints to their published versions automatically.

Posting on medRxiv does not preclude journal publication - the overwhelming majority of medical journals (including BMJ, The Lancet, JAMA, and NEJM) accept manuscripts previously posted as preprints, though a small number of journals still have restrictive policies, so check before posting. medRxiv also offers a direct transfer service (M2J) that transmits your manuscript files and metadata straight to more than 150 partner journals, saving re-entry time. Many journals can likewise deposit submitted manuscripts to medRxiv on the author's behalf.

medRxiv is completely free: no submission fee, no posting fee, no reader paywall. Authors retain copyright and choose a reuse license at submission - CC BY, CC BY-NC, CC BY-ND, CC BY-NC-ND, CC0, or "no reuse." Funders including NIH, Wellcome, and the Gates Foundation encourage or require preprint deposition, and a CC BY license maximizes compliance and reuse.

medRxiv applies enhanced checks appropriate to medical research: mandatory ethics-approval and consent declarations, mandatory trial registration for clinical trials, competing-interest and funding statements, and health-risk screening before posting. Manuscripts are permanent once posted - they can be marked "Withdrawn" with a stated reason but are not deleted, preserving the scholarly record.